Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Multiple novel hepatocellular carcinoma signature genes are commonly controlled by the master pluripotency factor OCT4

17 Dec 2019

Abstract excerpt

BACKGROUND: Worldwide, hepatocellular carcinoma (HCC) is a common solid tumor with a poor prognosis. HCC is often due to hepatitis B virus (HBV) infection. As yet, efficacious HCC treatment regimens for late-stage HCC patients are lacking. Therefore, the identification of more specific and sensitive biomarkers for its early diagnosis and treatment remains an urgent need. METHODS: Total RNAs from paired...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Hypoxia, and Metabolism
Share to Hepatocellular Carcinoma Treatment and Prognosis
Share to Histone Deacetylase Inhibitors Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31848930
DOI: 10.1007/s13402-019-00487-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Multiple novel hepatocellular carcinoma signature genes are commonly controlled by the master pluripotency factor OCT4PMID 31848930Read ↗

Novel hepatocellular carcinomas (HCC) Subtype-Specific BiomarkersSemantic proximity Read ↗

Comprehensive Transcriptomic Analysis of Hepatocellular Carcinoma: Uncovering Shared and Unique Molecular Signatures Across Diverse EtiologiesSemantic proximity Read ↗

Comprehensive analysis of transcriptome profiles in hepatocellular carcinomaSemantic proximity Read ↗

Advances in molecular classification and precision oncology in hepatocellular carcinoma.Semantic proximity Read ↗

Transcriptomic analysis and Novel gene pair-based signatures for Hepatitis B-related hepatocellular carcinomaSemantic proximity Read ↗

A comprehensive comparison of molecular and phenotypic profiles between hepatitis B virus (HBV)-infected and non-HBV-infected hepatocellular carcinoma by multi-omics analysis.Semantic proximity Read ↗

Machine learning and multi-omics data reveal driver gene-based molecular subtypes in hepatocellular carcinoma for precision treatment.Semantic proximity Read ↗

A novel epithelial–mesenchymal transition gene signature for the immune status and prognosis of hepatocellular carcinomaSemantic proximity Read ↗

Identification of an E2F Target‐Related Gene Signature to Improve the Prognosis Prediction for Patients with Hepatocellular CarcinomaSemantic proximity Read ↗

Genetic diversity of hepatocellular carcinomas and its potential impact on targeted therapies.Semantic proximity Read ↗

Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets.Semantic proximity Read ↗

Identification of a Novel Eight‐lncRNA Prognostic Signature for HBV‐HCC and Analysis of Their Functions Based on Coexpression and ceRNA NetworksSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.